Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
This overview explains the primary reasons stablecoins maintain stability, focusing on peg strategies, reserve health, and liquidity considerations.
19,944 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Nuvation Bio has surged, even as an insider sold a meaningful stake. This piece breaks down what the move means, how ...
This deep dive breaks down alto 2025 earnings, focusing on Q4 results, revenue growth, and what management signals fo...
Dogecoin just plunged below a critical level, triggering concern among traders and long-term holders alike. This guid...
Gold rallied as market chatter around with iran sending gold stoked safe-haven demand. Investors are weighing how thi...
Warren Buffett has paused his annual gift to the Gates Foundation, signaling a shift in a years-long philanthropic pa...
A soon-to-retire investor outlines a simple, income-centric ETF strategy built around three funds—JEPQ, DIVO, and SPH...
A surge in investor interest centers on SPCX as SpaceX expands its orbit into launches, satellite networks, and AI ve...
Tesla is signaling a bold move beyond traditional EVs. This article examines tesla stock's bold strategic shift, what...
U.S. regulators move to clear the way for civilian supersonic flights over the continental United States, setting noi...
A couple earning $107,000 gross confronts nearly $300,000 in student loans. Dave Ramsey’s blunt timeline sparks fresh...
Bitcoin could fall into the 40k zone as demand cools and momentum fades. Analysts warn that the bear cycle may extend...